Skip to content

Application of muscle force displacement device in studying the effect of comfortable anesthesia on muscle strength of resuscitated patients

Application of muscle force displacement device in studying the effect of comfortable anesthesia on muscle strength of resuscitated patients

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200063061
Enrollment
Unknown
Registered
2022-08-29
Start date
2022-08-31
Completion date
Unknown
Last updated
2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eye surgery

Interventions

Experimental group:Remimazolam besylate 0.1 mg/kg and alfentanil 5 ug/kg, when movement occurs, add Remimazolam 0.05 mg/kg and alfentanil 2.5 ug/kg
Control group:1% lidocaine 10 ml, and an equal volume of normal saline

Sponsors

Hangzhou Plastic Surgery Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 16-70 years who underwent periorbital surgery, regardless of sex; 2. BMI 19-28 kg/m2; 3. No serious respiratory, circulatory or mental illness; 4. Voluntary participation in the research.

Exclusion criteria

Exclusion criteria: 1. Previous history of recovery from anesthesia for abnormal surgery; 2. Patients with acute respiratory infection; those who are predicted to have or have experienced difficult airway, such as the modified Markov grade 3-4; 3. Those who are allergic to narcotic drugs, local anesthetics and their excipients; 4. Patients with family planning; 5. Patients suffering from high blood pressure, low blood pressure, respiratory diseases or other diseases; 6. Patients who have participated in other clinical research within three months; 7. Patients considered by other researchers to be unsuitable for participating in this study.

Design outcomes

Primary

MeasureTime frame
fine muscle strength;

Countries

China

Contacts

Public ContactHuang Yunping

Hangzhou Plastic Surgery Hospital

1973166043@qq.com+86 13867420976

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026